Prognostic value of TP53 transcriptional activity on p21 and bax in patients with esophageal squamous cell carcinomas treated by definitive chemoradiotherapy. [electronic resource]
Producer: 20021030Description: 379-85 p. digitalISSN:- 0360-3016
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- administration & dosage
- Confidence Intervals
- Esophageal Neoplasms -- drug therapy
- Female
- Fluorouracil -- administration & dosage
- Humans
- Male
- Middle Aged
- Mutation -- physiology
- Ploidies
- Prognosis
- Prospective Studies
- Proto-Oncogene Proteins -- metabolism
- Proto-Oncogene Proteins c-bcl-2
- Proto-Oncogene Proteins p21(ras) -- metabolism
- Survival Rate
- Transcriptional Activation
- Tumor Suppressor Protein p53 -- genetics
- bcl-2-Associated X Protein
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.